SCHEMBL21372902

SCHEMBL21372902

ONC(=Nc1cccc(Cl)c1)c1ccnc2nc[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 8/20 0.46
CYP3A4 P08684 1/20 0.44
CYP3A5 P20815 1/20 0.44
CDC7 O00311 4/20 0.42
DBF4 Q9UBU7 4/20 0.42
LMNA P02545 1/20 0.42
TMIGD3 P0DMS9 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
TDO2 P48775 1/20 0.39
HTR3E A5X5Y0 1/20 0.38
SLC22A2 O15244 1/20 0.38
SLC22A1 O15245 1/20 0.38
SLC22A3 O75751 1/20 0.38
HTR3B O95264 1/20 0.38
PLAU P00749 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
BRAF P15056 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21372715 0.88 IDO1 (0.46) IDO1CYP3A4CYP3A5CDC7DBF4
SCHEMBL21372664 0.86 ALDH1A1 (0.47) IDO1CYP3A4CYP3A5CDC7DBF4
SCHEMBL21373095 0.86 IDO1 (0.39) IDO1CYP3A4TDO2HTR3EHTR3B
SCHEMBL21372682 0.85 IDO1 (0.52) IDO1TDO2BRAF
SCHEMBL21372683 0.84 IDO1 (0.46) IDO1CDC7DBF4LMNAHTR3E
SCHEMBL21372871 0.84 IDO1 (0.47) IDO1CYP3A4CDC7DBF4
SCHEMBL21372956 0.84 IDO1 (0.47) IDO1CYP3A4CYP3A5CDC7DBF4
SCHEMBL21373029 0.84 IDO1 (0.39) IDO1CYP3A4CYP3A5LMNATDO2
SCHEMBL21372781 0.84 IDO1 (0.42) IDO1CYP3A4CYP3A5TDO2BRAF
SCHEMBL21372804 0.82 IDO1 (0.38) IDO1CYP3A4CYP3A5TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294732-B1 BENZIMIDAZOLE AND IMADAZOPYRIDINE CARBOXIMIDAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE GILEAD SCIENCES INC (US) 2019-09-25 EP claimed